Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Genet.

Sec. Cancer Genetics and Oncogenomics

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1614946

This article is part of the Research TopicComparative Genomics and Functional Genomics Analyses in CancerView all 8 articles

Integrative multi-omics analysis and machine learning reveal the unique role of ASCC3 in combination with various immune-related genes in rectal adenocarcinoma

Provisionally accepted
  • 1Department of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China
  • 2School of Medicine, Nantong University, Nantong, Jiangsu Province, China

The final, formatted version of the article will be published soon.

Background: The Activating Signal Cointegrator 1 (ASC-1) complex is a tetrameric complex composed of Thyroid Hormone Receptor Interactor 4 (TRIP4), Activating Signal Cointegrator 1 (ASCC1), Activating Signal Cointegrator 2 (ASCC2), and Activating Signal Cointegrator 3 (ASCC3). As the core subunit of the ASC-1 complex, ASCC3 is involved in DNA damage repair. However, the exact role of ASCC3 in digestive system cancers, particularly in rectal adenocarcinoma(READ), remains unclear. Methods: We utilized data from The Cancer Genome Atlas (TCGA) and GEO to investigate the prognostic value of the four subunits, with a focus on ASCC3, in pan-cancers including rectal adenocarcinoma. Additionally, we explored the regulatory mechanisms of ASCC3 and its association with tumor immunity in rectal adenocarcinoma using TIMER, IMMPORT, DAVID databases, and CIBERSORT analysis. Prognostic models were constructed using ssGSEA analysis and various machine learning algorithms. We explored the signaling pathways regulated by ASCC3 using the CancerSEA and TCPA databases. Furthermore, mutations of ASCC3 in pan-cancer were investigated using the PFAM and CbioPortal databases. Finally, we performed interaction network analysis of ASCC3 using STRING, ComPPI, and BioGRID databases. Results: ASCC3 is a specific protective factor for rectal adenocarcinoma across various cancer types, particularly in digestive system cancers, and can synergize with several immune-related genes, including JAK1, NFKB1, SEMA5A, NR2C2, CNTF, and CREB1, to influence patient prognosis. Furthermore, ASCC3 may regulate tumor immunity by affecting T cell function. Conclusion: ASCC3 can serve as an independent prognostic factor for READ and can synergize with various immune-related genes to influence patient prognosis.

Keywords: Read, ASCC3, machine learning, prognosis, tumor immunity, DNA damage repair, genome stability

Received: 20 Apr 2025; Accepted: 31 Jul 2025.

Copyright: © 2025 Miao and Qian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Fei Qian, Department of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.